BioSpace News Archive

Provides fast pain relief, returns patients to normal function within one hour and delivers sustained efficacy that lasts up to 48 hours for many patients

Regulus Therapeutics Inc. reported financial results for the fourth quarter and year ended December 31, 2019 and provided a corporate update.

The Canadian Medical Association is taking steps to respond to the situation on three levels – we are advocating at the federal level on key issues identified by the medical community;

Helix BioPharma Corp. announced it has closed a private placement financing of 5,042,016 units of the Company at a price of $1.0332 per Unit, and the concurrent disposition of 1,708,023 shares of the Company’s Polish subsidiary, Helix Immuno-Oncology S.A., to a third-party purchaser, representing an 15.5% equity stake in HIO, for aggregate gross proceeds of CAD $6,000,000, or $1.19 per Purchased Security.

China Biologic Products Holdings, Inc. announced its financial results for the fourth quarter and fiscal year of 2019.

The California Pharmacists Association, the largest statewide pharmacy association representing all pharmacy practice settings, has announced the transition of Western Pharmacy Exchange from a live, in-person conference, to a solely virtual experience to ensure the health and safety of all pharmacy professionals, exhibitors, academic institutions, and industry partners.

Bio-Rad Laboratories, Inc. announced that through its Exact Diagnostics product line Bio-Rad has launched a SARS CoV-2 Standard to support laboratory assay validation of coronavirus testing.

A recent research report on Global Healthcare Claims Management Solutions Market 2020 deeply studied great features of the industry.

A recent research report on Global Healthcare Contract Research Organization Market 2020 deeply studied great features of the industry.

A recent research report on Global Hospital Acquired Infection Diagnostics Market 2020 deeply studied great features of the industry. The analysis serves market size, Hospital Acquired Infection Diagnostics ongoing trends, drivers, risks, possibilities, as well as principal segments. It is primarily based on historical information and present Hospital Acquired Infection Diagnostics market requirements. Also, includes different Hospital Acquired Infection Diagnostics business approaches preferr